Correlation Between Advanced Proteome and ChitogenX
Can any of the company-specific risk be diversified away by investing in both Advanced Proteome and ChitogenX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Advanced Proteome and ChitogenX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Advanced Proteome Therapeutics and ChitogenX, you can compare the effects of market volatilities on Advanced Proteome and ChitogenX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Advanced Proteome with a short position of ChitogenX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Advanced Proteome and ChitogenX.
Diversification Opportunities for Advanced Proteome and ChitogenX
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Advanced and ChitogenX is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Advanced Proteome Therapeutics and ChitogenX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChitogenX and Advanced Proteome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Advanced Proteome Therapeutics are associated (or correlated) with ChitogenX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChitogenX has no effect on the direction of Advanced Proteome i.e., Advanced Proteome and ChitogenX go up and down completely randomly.
Pair Corralation between Advanced Proteome and ChitogenX
If you would invest 0.02 in Advanced Proteome Therapeutics on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Advanced Proteome Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Advanced Proteome Therapeutics vs. ChitogenX
Performance |
| Timeline |
| Advanced Proteome |
| ChitogenX |
Advanced Proteome and ChitogenX Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Advanced Proteome and ChitogenX
The main advantage of trading using opposite Advanced Proteome and ChitogenX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Advanced Proteome position performs unexpectedly, ChitogenX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChitogenX will offset losses from the drop in ChitogenX's long position.| Advanced Proteome vs. Rezolute | Advanced Proteome vs. Tempest Therapeutics | Advanced Proteome vs. Forte Biosciences | Advanced Proteome vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |